| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-550 | |
| Phytochemical name or plant extracts | Liriopem II (2) | |
| PMID | 26073343 | |
| Literature evidence | In summary, compounds 1 and 2 identified in the present study exerted cytotoxicity against breast cancer cells, providing a basis for future development of these compounds as novel anticancer agents. | |
| IUPAC name | 25(R, S)- ruscogenin-1-O-[β-D-fucopyranosyl (1→2)]-[β-D-xylopyranosyl(1→4)]-β-D-fucopyranoside (Liriopem II, 2 | |
| Phytochemicals’ class or type of plant extracts | Glycoside | |
| Source of phytochemicals or plant Extracts | Liriope muscari | |
| Geographical availability | China North-Central, China South-Central, China Southeast, Japan, Korea, Nansei-shoto, Taiwan | |
| Plant parts | Root | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 0.05 ± 0.10 μg/ml against MDA-MB-435 | |
| Potency | In summary, compounds 1 and 2 identified in the present study exerted cytotoxicity against breast cancer cells, providing a basis for future development of these compounds as novel anticancer agents. | |
| Cell line/ mice model | MDA-MB-435 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:537868-1 | |
| Safety | NA |